In addition, the compound significantly inhibited mTOR phosphorylationat its IC50 concentration, thereby negatively modulatingthe PI3K/Akt/mTOR axis, which represents an escape for the dependencyfrom ER signaling in BC cells. The gene discussed is AKT1; the disease is breast cancer.